IotaMotion Strengthens Leadership in Robotic Cochlear Implant Surgery with New Patent

Advancements in Robotic Cochlear Implantation

IotaMotion, Inc., a pioneer in the field of robotic-assisted cochlear implantation systems, has announced a significant advancement in its intellectual property portfolio by securing U.S. Patent No. 12,558,123. This new patent further solidifies IotaMotion's leadership in the surgical landscape of cochlear implants, particularly with its flagship product, iotaSOFT®.

The iotaSOFT® Robotic-Assisted Insertion System

The iotaSOFT® system is groundbreaking as it is the first and only FDA-cleared robotic-assisted cochlear implant insertion system available in the market. Designed for patients four years and older, this innovative technology enables a slow, consistent, and controlled insertion of electrodes into the cochlea, thereby preserving delicate intracochlear structures. The system addresses a critical gap in cochlear implantation, as less than 5% of the approximately 60 million individuals worldwide who could benefit from cochlear implants actually receive them.

According to the World Health Organization (WHO), over 430 million people suffer from disabling hearing loss, underlining the need for effective cochlear implantation solutions. The iotaSOFT® system not only enhances surgical precision but also contributes to a potentially wider uptake of cochlear implants by ensuring better outcomes for patients.

Commitment to Advancing Cochlear Surgery

Mike Lobinsky, CEO of iotaMotion, stated, "This new patent complements our strong IP portfolio, which broadly covers systems and methods related to robotic positioning and control in cochlear surgery. As the iotaSOFT system becomes increasingly integrated into leading cochlear implantation centers, protecting the technologies that standardize and control electrode insertion is essential for maintaining our leadership in this field."

The iotaSOFT system's ability to transcend human limitations in surgery is revolutionary. By providing consistent and controlled electrode placement, it preserves fragile cochlear structures better than traditional methods. Currently available in the United States, the system is gaining traction and recognition in clinical settings, which is vital for the future of cochlear implantation technology.

Future Innovations and Global Impact

As robotic-assisted technology continues to see increased adoption in clinical practices, the strength of IotaMotion's intellectual property will be crucial in facilitating sustained innovation and long-term progress in this medical field. The ongoing clinical studies are set to explore other global markets, promising a more significant impact on hearing restoration worldwide.

IotaMotion, based in St. Paul, Minnesota, is committed to pushing the boundaries of cochlear surgery beyond human capabilities through robotic-assisted innovations. The company's flagship iotaSOFT system is meticulously designed to provide a gradual and controlled insertion of electrode arrays, ensuring patient safety and improved surgical outcomes.

For further details, interested parties can visit IotaMotion's official website or connect with them on social media platforms like LinkedIn, X, Facebook, and YouTube. The advancements in cochlear implant technology herald a new era of hope for millions who might otherwise go untreated, and IotaMotion stands at the forefront of this transformative journey.